Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jaspreet S. Batra
Pilot Study of Hyperfractionated Dosing of Lutetium‐177–Labeled Antiprostate‐Specific Membrane Antigen Monoclonal Antibody J591 ( 177 Lu‐J591) for Metastatic Castration‐Resistant Prostate Cancer
Oncologist
Cancer Research
Medicine
Oncology
Related publications
[ 177 Lu]-Psma-617 Radionuclide Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer – Author's Reply
The Lancet Oncology
Oncology
Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
Cancer Journal
Cancer Research
Oncology
Prostate-Specific Membrane Antigen Based Antibody-Drug Conjugates for Metastatic Castration-Resistance Prostate Cancer
Cureus
A Prospective Pilot Study of 89Zr-J591/Prostate Specific Membrane Antigen Positron Emission Tomography in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy
Journal of Urology
Urology
Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer With 177 Lu-Psma-617
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
A Phase II Trial of Prostate-Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC) in Taxane-Refractory Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Dosimetry of Lu-177 PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pre-Therapeutic Imaging and “Whole Body” Tumor Dosimetry With Treatment Outcomes
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Radioimmunotherapy of Prostate Cancer Using 90y- And 177Lu-Labeled J591 Monoclonal Antibodies: Effect of Multiple Treatments on Myelotoxicity
Clinical Cancer Research
Cancer Research
Oncology
Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
